Autoantibodies and Arrhythmias: An Underexplored Link in Myocarditis
Myocarditis is an inflammatory disease that may be associated with severe acute and chronic complications, including progression to inflammatory cardiomyopathy, characterized by persistent inflammation, cardiac dysfunction, and adverse ventricular remodeling. Arrhythmias are major determinants of morbidity and mortality across this disease spectrum and have traditionally been attributed to structural substrates such as myocardial edema, necrosis, and fibrosis. However, as the role of the immune system in myocarditis is increasingly recognized, growing attention has been focused on immune-mediated mechanisms capable of directly perturbing cardiac excitability. Circulating cardiac autoantibodies are frequently detected in patients with myocarditis. Beyond their potential diagnostic value, specific autoantibody subsets have been hypothesized to exert pathogenic effects by targeting receptors, ion channels, contractile proteins, and intercalated disk components involved in impulse generation, conduction, repolarization, calcium handling, and myocardial structural integrity. This narrative review evaluates the mechanistic basis of autoimmune arrhythmias, the available preclinical and clinical evidence linking autoantibodies to atrial and ventricular arrhythmias, and the potential role of autoantibody profiling in refining arrhythmic risk stratification. Particular attention is given to distinguishing direct evidence obtained in patients with myocarditis and inflammatory cardiomyopathy from findings derived from other cardiac or systemic diseases and experimental models, whose applicability to myocardial inflammatory disorders remains uncertain. Finally, we critically evaluate whether autoantibody testing may help identify patients more likely to benefit from immunomodulatory or immunosuppressive strategies, while emphasizing the current limitations related to small observational cohorts and the lack of randomized trials evaluating antibody-guided treatment strategies with dedicated arrhythmic endpoints.
Authors
- Francesco Tona (ORCID: https://orcid.org/0000-0003-4828-7875)
- Giovanni Civieri (ORCID: https://orcid.org/0000-0002-3076-4787)
- Marta Vadori (ORCID: https://orcid.org/0000-0002-9763-2383)
- Donatella Tansella (ORCID: https://orcid.org/0009-0005-9684-6426)
- Laura Iop (ORCID: https://orcid.org/0000-0002-7034-9414)
- Alberto Marmai (ORCID: https://orcid.org/0009-0002-4385-3575)
- Emanuele Cozzi
Institutions
- University of Padua (IT)
Publication Details
- Journal
- Journal of Cardiovascular Development and Disease
- Published
- 2026-11-16
- DOI
- https://doi.org/10.3390/jcdd13110598
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00